The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

While there’s no cure for multiple sclerosis (MS), there are many treatments available. These treatments mainly focus on slowing down the progression of the disease and managing symptoms.

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...

Multiple sclerosis (MS) is an autoimmune neurological ... your doctor will suggest different treatments to help treat symptoms and improve your quality of life. Just as the two conditions are ...

A new study revealed safe MS treatment options during pregnancy, reassuring women to balance effective care with their plans ...

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics ...

This report covers recent health news, including Robert F. Kennedy Jr.'s legal fees from Merck litigations, rejections of a ...